首页|恶性高血压肾硬化的临床病理特征及预后分析

恶性高血压肾硬化的临床病理特征及预后分析

扫码查看
目的 探究原发性恶性高血压肾硬化(malignant hypertensive nephrosclerosis,MHTN)患者的临床病理及预后特征,明确影响MHTN患者预后的关键因素.方法 收集 2012 年 12 月至 2023 年 6 月空军军医大学西京医院经肾活体组织检查确诊的高血压肾病患者的病理及临床资料,根据病理结果区分MHTN和良性肾动脉硬化(benign arteriolosclerosis nephrosclerosis,BAN).采用单因素和多因素Cox回归分析确定影响MHTN患者肾脏预后的危险因素,通过Kaplan-Meier生存曲线计算肾脏累积生存率.研究终点定义为终末期肾病或死亡的复合终点.结果 共计 231 例原发性高血压肾病患者纳入研究,其中MHTN患者 75例,中位随访时间为 20.8(13.2,47.1)个月,共 36 例(52.0%)达到肾脏复合终点.与BAN患者相比,MHTN患者平均年龄更小、临床表现更重、预后更差.单因素Cox分析显示,估算肾小球滤过率(estimated glomerular filtration rate,eGFR)、尿微量白蛋白肌酐比、N-乙酰-β-D氨基葡萄糖苷酶、血浆白蛋白、血清钙、胱抑素C(cystatin C,Cys-C)、血红蛋白(hemoglobin,Hb)、纤维蛋白原(fibrinogen,FIB)和肾脏总体慢性病理评分(Total Renal Chronic Pathological Score,TRCS)与MHTN患者肾脏复合终点的发生风险增加相关.校正病理评分后的多因素Cox分析显示,Cys-C(HR=1.490,95%CI:1.144~1.942,P=0.003)、Hb(HR=0.981,95%CI:0.963~0.999,P=0.042)、FIB(HR=1.650,95%CI:1.125~2.419,P=0.010)、TRCS(HR=1.317,95%CI:1.057~1.640,P=0.014)是影响MHTN患者肾脏预后的独立危险因素.结论 在MHTN患者中,Cys-C、FIB升高、Hb降低和更严重的肾脏病理改变预示着不良肾脏结局.进一步提升临床诊疗过程中MHTN患者的肾活体组织检查率更有助于评估患者预后.
Analysis of clinicopathological characteristics and prognosis of malignant hypertensive nephrosclerosis
Objective To explore the clinicopathological and prognostic characteristics of patients with primary malignant hypertensive nephrosclerosis(MHTN)and identify the key factors influencing the prognosis of MHTN patients.Methods The pathological and clinical data of hypertensive nephropathy patients diagnosed by renal biopsy in Xijing Hospital of Air Force Medical University from December 2012 to June 2023,were collected.Patients were distinguished into MHTN and benign arteriolosclerosis nephrosclerosis(BAN)groups based on pathological results.Univariate and multivariate Cox regression analyses were performed to identify the risk factors affecting renal prognosis in MHTN patients.Kaplan-Meier survival curves were used to calculate renal cumulative survival rates.The study endpoint was defined as a composite endpoint of end-stage renal disease or death.Results A total of 231 patients with primary hypertensive nephropathy were included in the study,of which 75 were MHTN patients.The median follow-up time was 20.8(13.2,47.1)months,and 36(52.0%)patients reached the renal composite endpoint.Compared with BAN patients,MHTN patients had more severe clinical manifestations,worse prognosis,and younger average age.Univariate Cox analysis showed that estimated glomerular filtration rate(eGFR),urinary microalbumin creatinine ratio,urinary N-acetyl-β-D-glucosaminidase,plasma albumin,serum calcium,cystatin C(Cys-C),hemoglobin(Hb),fibrinogen(FIB),and total renal chronic pathological score(TRCS)were associated with an increased risk of renal composite endpoints in MHTN patients.Multivariate Cox regression after adjusting for pathological scores revealed that Cys-C(HR=1.490,95%CI:1.144-1.942,P=0.003),Hb(HR=0.981,95%CI:0.963-0.999,P=0.042),FIB(HR=1.650,95%CI:1.125-2.419,P=0.010),and TRCS(HR=1.317,95%CI:1.057-1.640,P=0.014)were independent risk factors for renal prognosis in MHTN patients.Conclusions In MHTN patients,elevated Cys-C and FIB levels,decreased Hb,and severe pathological changes predict adverse renal outcomes.Further increasing the rate of renal biopsy in MHTN patients during clinical diagnosis and treatment can help assess their prognosis.

malignant hypertensive nephrosclerosisbenign renal arteriosclerosischronic kidney diseaserisk factorsprognosis of kidney

秦云龙、周瑾、刘萌、罗开发、王安静、王頔、赵晋、孙世仁

展开 >

空军军医大学西京医院肾脏内科,西安 710032

联勤保障部队第九八○医院肾脏病科,石家庄 050021

解放军95561部队保障部门诊部,拉萨 850000

恶性高血压肾硬化 良性肾动脉硬化 慢性肾脏病 危险因素 肾脏预后

国家自然科学基金项目

82170722

2024

首都医科大学学报
首都医科大学

首都医科大学学报

CSTPCD北大核心
影响因子:1.511
ISSN:1006-7795
年,卷(期):2024.45(5)